The stock of CVS Health Corp (CVS) has gone up by 0.81% for the week, with a -0.95% drop in the past month and a -10.80% drop in the past quarter. The volatility ratio for the week is 2.12%, and the volatility levels for the past 30 days are 2.47% for CVS. The simple moving average for the past 20 days is 2.75% for CVS’s stock, with a -12.89% simple moving average for the past 200 days.
Is It Worth Investing in CVS Health Corp (NYSE: CVS) Right Now?
The price-to-earnings ratio for CVS Health Corp (NYSE: CVS) is above average at 10.55x, Company’s 36-month beta value is 0.51.Analysts have differing opinions on the stock, with 10 analysts rating it as a “buy,” 5 as “overweight,” 9 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CVS is 1.25B, and currently, short sellers hold a 1.42% ratio of that floaft. The average trading volume of CVS on July 26, 2024 was 12.73M shares.
CVS) stock’s latest price update
The stock price of CVS Health Corp (NYSE: CVS) has surged by 2.40 when compared to previous closing price of 58.65, but the company has seen a 0.81% gain in its stock price over the last five trading sessions. zacks.com reported 2024-07-25 that The latest trading day saw CVS Health (CVS) settling at $58.65, representing a +0.19% change from its previous close.
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with Robert W. Baird repeating the rating for CVS by listing it as a “Neutral.” The predicted price for CVS in the upcoming period, according to Robert W. Baird is $61 based on the research report published on May 30, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see CVS reach a price target of $59, previously predicting the price at $99. The rating they have provided for CVS stocks is “Hold” according to the report published on May 07th, 2024.
UBS gave a rating of “Neutral” to CVS, setting the target price at $60 in the report published on May 02nd of the current year.
CVS Trading at 2.29% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.86% of loss for the given period.
Volatility was left at 2.47%, however, over the last 30 days, the volatility rate increased by 2.12%, as shares surge +3.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.45% upper at present.
During the last 5 trading sessions, CVS rose by +1.01%, which changed the moving average for the period of 200-days by -15.55% in comparison to the 20-day moving average, which settled at $58.54. In addition, CVS Health Corp saw -23.94% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from Mahoney Michael F, who purchase 9,181 shares at the price of $54.49 back on May 02 ’24. After this action, Mahoney Michael F now owns 9,356 shares of CVS Health Corp, valued at $500,294 using the latest closing price.
LUDWIG EDWARD J, the Director of CVS Health Corp, purchase 1,000 shares at $53.88 during a trade that took place back on May 02 ’24, which means that LUDWIG EDWARD J is holding 21,630 shares at $53,879 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.15 for the gross margin
The net margin for CVS Health Corp stands at 0.02. The total capital return value is set at 0.07. Equity return is now at value 10.07, with 2.99 for asset returns.
Based on CVS Health Corp (CVS), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at 0.13. The debt to equity ratio resting at 1.11. The interest coverage ratio of the stock is 4.47.
Currently, EBITDA for the company is 18.44 billion with net debt to EBITDA at 4.25. When we switch over and look at the enterprise to sales, we see a ratio of 0.41. The receivables turnover for the company is 11.16for trailing twelve months and the total asset turnover is 1.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.81.
Conclusion
In a nutshell, CVS Health Corp (CVS) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
